These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 11009543)
61. Inspecting the quality of drugs. Battaglino G Boll Chim Farm; 1983 Dec; 122(12):575-81. PubMed ID: 6675724 [No Abstract] [Full Text] [Related]
62. The role of university technology transfer operations in assuring access to medicines and vaccines in developing countries. Nelsen L Yale J Health Policy Law Ethics; 2003; 3(2):301-8. PubMed ID: 14577146 [No Abstract] [Full Text] [Related]
63. The introduction of new vaccines into developing countries. IV: Global Access Strategies. Mahoney RT; Krattiger A; Clemens JD; Curtiss R Vaccine; 2007 May; 25(20):4003-11. PubMed ID: 17363119 [TBL] [Abstract][Full Text] [Related]
64. Bad medicine in the market. Roger B; Boateng K World Hosp Health Serv; 2007; 43(3):17-21. PubMed ID: 18269104 [TBL] [Abstract][Full Text] [Related]
65. [Production and quality control of vaccines]. Pfleiderer M Pharm Unserer Zeit; 2008; 37(1):28-38. PubMed ID: 18081076 [No Abstract] [Full Text] [Related]
67. [Facing the problem of standardization and control of medical biological preparations in the USSR]. Dzagurov SG Zh Mikrobiol Epidemiol Immunobiol; 1972 Aug; 49(8):20-5. PubMed ID: 5086022 [No Abstract] [Full Text] [Related]
69. Introductory note to the three-part series of papers by Basant Sharma on: immunogenicity of therapeutic proteins: how to assess and the role of pharmaceutical quality. Trouvin JH Biotechnol Adv; 2007; 25(3):307-9. PubMed ID: 17321095 [No Abstract] [Full Text] [Related]
70. [Counterfeiting of medicines, as a life threatening world tendency]. Horgos J; Bartus G; Szente V; Hankó B; Zelkó R Acta Pharm Hung; 2009; 79(2):88-91. PubMed ID: 19634640 [TBL] [Abstract][Full Text] [Related]
71. Will bad times ever end for world's poorest children? Sibbald B CMAJ; 2002 Apr; 166(9):1198. PubMed ID: 12000258 [No Abstract] [Full Text] [Related]
72. Medicines in developing countries: a global health concern. American Public Health Association Am J Public Health; 1991 Feb; 81(2):256-60. PubMed ID: 11642868 [No Abstract] [Full Text] [Related]
73. Children can't wait: improving the future for the world's poorest infants. Stoll BJ; Measham AR J Pediatr; 2001 Nov; 139(5):729-33. PubMed ID: 11713454 [No Abstract] [Full Text] [Related]
74. Family planning in developing nations: a global concern, our concern. Harriman L J Home Econ; 1984; 76(1):8-12. PubMed ID: 12339668 [TBL] [Abstract][Full Text] [Related]
75. Assuring the quality and safety of vaccines: regulatory licensing and batch release. Griffiths E; Knezevic I Methods Mol Med; 2003; 87():353-76. PubMed ID: 12958467 [No Abstract] [Full Text] [Related]
76. [Vaccinology: the development, preparation, control and administration of vaccines]. Ruitenberg EJ Ned Tijdschr Geneeskd; 1989 Apr; 133(17):863-4. PubMed ID: 2725743 [No Abstract] [Full Text] [Related]
77. Quality-control issues and approaches in vaccine development. Metz B; van den Dobbelsteen G; van Els C; van der Gun J; Levels L; van der Pol L; Rots N; Kersten G Expert Rev Vaccines; 2009 Feb; 8(2):227-38. PubMed ID: 19196202 [TBL] [Abstract][Full Text] [Related]
79. New countermeasures considered as drug counterfeiting grows. Schubert C Nat Med; 2008 Jul; 14(7):700. PubMed ID: 18607355 [No Abstract] [Full Text] [Related]
80. The state of the world's pharmacy: a portrait of the pharmacy profession. Anderson S J Interprof Care; 2002 Nov; 16(4):391-404. PubMed ID: 12487847 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]